Cartesian Therapeutics
RNAC
#7076
Rank
A$0.55 B
Marketcap
$24.18
Share price
-5.18%
Change (1 day)
-50.19%
Change (1 year)

Cartesian Therapeutics (RNAC) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : A$0.67 B

According to Cartesian Therapeutics's latest financial reports the company's total liabilities are A$0.67 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cartesian Therapeutics - Total liabilities on balance sheet (from 2015 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$1.09 B933.01%
2022-12-31A$0.10 B-43.95%
2021-12-31A$0.18 B-20.64%
2020-12-31A$0.23 B83.55%
2019-12-31A$0.12 B83.17%
2018-12-31A$70.8 M12.16%
2017-12-31A$63.13 M32.5%
2016-12-31A$47.64 M-78.22%
2015-12-31A$0.21 B63.07%
2014-12-31A$0.13 B